tiprankstipranks
Trending News
More News >
Innovent Biologics (HK:1801)
:1801
Advertisement

Innovent Biologics (1801) Revenue

Compare
21 Followers

Innovent Biologics Revenue

Innovent Biologics had a revenue of 5.95B in the quarter ending Jun 30, 2025, with 8.84%. This bring the company's revenue in the last twelve months to 11.42B, Decreased 21.24%. In the fiscal year ending Dec 31, 2024, Innovent Biologics had annual revenue of 9.42B with 51.82% growth.
Revenue (ttm)
11.42B
Revenue Growth
52.78%
P/S Ratio
17.52
Revenue/Employee
$1,664,939
Employees
5,659
Market Cap
$165.11B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
9.42B3.22B+151.82%
Dec 31, 2023
6.21B1.65B+136.21%
Dec 31, 2022
4.56B286.65M+106.71%
Dec 31, 2021
4.27B425.91M+111.08%
Dec 31, 2020
3.84B2.80B+366.94%
Dec 31, 2019
1.05B1.04B+11,053.34%
Dec 31, 2018
9.48M-9.06M+51.12%
Dec 31, 2017
18.54M-13.59M+57.70%
Dec 31, 2016
32.13M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis